Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics.
List of Companies
Abbott Alfred E. Mann Foundation for Science Research Animas Corporation Baxter Bayer Cardiac Pacemakers Inc. Cercacor Laboratories Dexcom E. Heller & Company East West Bank Eyesense AG GLT Acquisition Corp. Glumetrics Inc. Hudson Bay Master Fund Isense Corporation Legacy Good Samaritan Hospital and Medical Center Lifescan Inc Markwell Medical Institute Medisense Medtronic Midcap Funding National Institutes of Health Oxygen Biotherapeutics Panasonic Roche Diagnostics Sensors for Medicine and Science Siemens Silver James H Therasense University of New Mexico Vivomedical Inc. Xoetronics LL